The FDA announced on March 21, 2025, that Zydus Pharmaceuticals (USA) Inc voluntarily recalled Venlafaxine Tablets, USP, 75 mg due to the presence of foreign material resembling a metal shaving. The agency issued recall number D-0310-2025 for the Class II product distributed nationwide.
How to tell if you have it
- Brand: Zydus Pharmaceuticals
- Product: Venlafaxine Tablets, USP, 75 mg, 100 Tablets, Rx only
- Manufacturer: Zydus Lifesciences Ltd, Ahmedabad, India
- Distributor: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534
- NDC: 68382-021-01
- Lot #: M314265
- Expiration Date: 31 October 2025
- Quantity: 13,128 100-Count Bottles
- Distribution: US Nationwide
The hazard
The recall addresses a product complaint regarding foreign material embedded in one tablet that resembles a metal shaving. The FDA classified the issue as Class II.
Context
GovInfoNow's records show Zydus Pharmaceuticals (USA) Inc has 53 other recalls on record since 2012-03-14. Recent Zydus recalls include a 2026-08-05 recall of Mirabegron 25mg Tablets for N-Nitroso Impurity Risk and a 2026-04-29 recall of Erythromycin Tablets for N-Nitroso-Desmethyl-Erythromycin Risk. Other recent recalls of similar products include Bionpharma Divalproex Tablets Recall (2026-06-26), Guardian Drug Family Wellness Antacid Tablets Recall (2026-05-28), and Guardian Drug Goodsense Ultra Strength Antacid Tablets Recall (2026-05-28).